Suggestions on how to purchase generic adagrasib (Krazati) drugs and select regular channels
Adagrasib (Krazati) is currently not available in the country, so domestic patients cannot purchase it directly through hospitals or regular pharmacies. This means that if patients need medication, they can only rely on foreign channels for procurement. When choosing a purchasing channel, you must be extra cautious to ensure that the source of the medicine is reliable and to avoid purchasing counterfeit or substandard medicines, which may affect the treatment effect or even endanger your health.
When purchasing adagrasib overseas, the original drug is mainly the American version, which is expensive, up to hundreds of thousands of yuan per box, and is a heavy financial burden for most patients. However, there are also generic drugs produced in Laos abroad. The price is relatively affordable, about more than 3,000 yuan per box. The ingredients of the drugs are basically the same as the original drugs, and the efficacy is relatively reliable, providing patients with an affordable alternative.
When choosing formal channels, it is recommended to purchase through international drug supply platforms authorized by well-known overseas pharmacies or hospitals, and ensure that the drugs have complete batch numbers, production dates, and expiration dates. At the same time, purchasing vouchers and logistics information should be retained so that if drug quality or transportation problems arise, they can be traced and dealt with in a timely manner. Never purchase from unknown individuals or unofficial channels to avoid security risks.
In addition, after purchasing drugs overseas, patients should maintain communication with their domestic doctors to confirm the dosage, course of treatment and monitoring plan. Regularly review blood routine, liver and kidney function and tumor indicators to ensure safe and effective drug use. Reasonable planning of purchase volume and medication cycle can not only reduce economic pressure, but also help ensure the continuity and efficacy of treatment.
Reference materials:https://www.drugs.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)